BGMA: Undue criticism of generics pricing 'winds me up'
• By Grace Lewis
The British Generic Manufacturers Association (BGMA) has stressed “there might be a good reason for a price to go up”, following a government bill to cap drug pricing.
exclusive
Warwick Smith: It's really important to get the right procedure for deciding if a price is set correctly
The association's director general Warwick Smith said the Health Service Medical Supplies (Costs) Bill – which received royal assent last month (April 28) – is designed to encourage greater transparency throughout the supply chain, when it comes to generics drug pricing.
Free to registered users
Register to gain full access to C+D and C+D Community content
Chair of the National Pharmacy Association (NPA) Nick Kaye has said that he “definitely wouldn't be thinking about a U-turn” on collective action, amid “real anger” over a lack of April cash.
CPE is recruiting a new independent chair to “provide strategic leadership” – the position pays £50k a year and only requires a “time commitment” of 3-4 working days per calendar month.